After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Stoke Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Stoke Therapeutics Inc is $530.73M. A total of 0.64 million shares were traded on the day, compared to an average of 656.86K shares.
In the most recent transaction, Skorpios Trust sold 2,000,000 shares of STOK for 11.50 per share on Dec 23 ’24. After the transaction, the 10% Owner now owns 6,906,181 company shares. In a previous transaction on Dec 23 ’24, Blue Horizon Enterprise Ltd bought 2,000,000 shares at 11.59 per share.
Among the insiders who sold shares, Ticho Barry disposed of 2,586 shares on Dec 09 ’24 at a per-share price of $12.99. This resulted in the CHIEF MEDICAL OFFICER holding 44,746 shares of STOK after the transaction. In another insider transaction, Allan Jonathan sold 13,666 shares at $13.61 per share on Dec 09 ’24. Company shares held by the GENERAL COUNSEL & CORP SEC now total 21,476.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, STOK has a high of $17.58 and a low of $4.09.
As of this writing, STOK has an earnings estimate of -$0.54 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of -$0.5 per share and a lower estimate of -$0.61.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. STOK’s latest balance sheet shows that the firm has $219.81M in Cash & Short Term Investments as of fiscal 2021. There were $1.51M in debt and $17.14M in liabilities at the time. Its Book Value Per Share was $4.38, while its Total Shareholder’s Equity was $217.78M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for STOK is Buy with a score of 4.70.
